<DOC>
	<DOCNO>NCT02413567</DOCNO>
	<brief_summary>The purpose study evaluate Fractyl Duodenal Mucosal Resurfacing ( DMR ) Procedure treatment Type 2 Diabetes .</brief_summary>
	<brief_title>Evaluation Duodenal Mucosal Resurfacing Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>28 75 year age Diagnosed Type 2 Diabetes less 10 year HbA1c 7.5 10.0 % ( 5986 mmol/mol ) BMI ≥ 24 ≤ 40 kg/m2 Diagnosed Type 1 Diabetes history ketoacidosis Probable insulin production failure , define fast C Peptide serum &lt; 1 ng/mL ( 333pmol/l ) Current use Insulin Use GLP1 analogue Active uncontrolled GERD define grade III esophagitis great Upper gastrointestinal condition ulcer , gastric varix , stricture , congenital acquire intestinal telangiectasia</criteria>
	<gender>All</gender>
	<minimum_age>28 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>